Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
3.900
-0.240 (-5.80%)
Aug 1, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Artificial Intelligence-driven DNA Biomarker Testing Technology
17.07K
Log In
Artificial Intelligence-driven DNA Biomarker Testing Technology Growth
1696.32%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
17.07K
Log In
United States Growth
1696.32%
Log In